ArticlePharmaceutics2022

Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate.

Bárbara Fernandes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.